Topic: MAT
In the News: Opioid Windfall
It does seem ironic that the industry most responsible for the creation and continuation of our current opioid epidemic could also be the main beneficiary of this next wave of treatment funding.
The Business of Cures
I’d feel better if I knew some in our brilliant science community were working hard on ways to taper patients, if just the most highly motivated, off the medications with a reduced risk of return to heroin.
Topics: MAT, opioids, prescription medications
Two Perspectives on Pain
We may be stuck relying on the soft stuff– therapy, support, behavior change, even spiritual growth– all those icky-squicky things that neuroscientists struggle to quantify.
Topics: MAT, opioids, pain, prescription medications, therapies and tools
Searching for a Substitute
If addiction really is a brain disorder based in complex adaptations to a substance, then who’s to say those adaptations won’t occur with a different drug?
Topics: addiction and the brain, kratom, maintaining sobriety, MAT, types of treatment
Naltrexone versus Opioids
Not surprisingly, the vast majority of patients who drop out or otherwise leave maintenance programs return to heroin at rates of 80% or higher.
Topics: addiction medications, harm reduction, MAT, therapies and tools
Methadone Maintenance Plus
It’s the basic unit of most drug-free approaches. What would happen if it could be incorporated into the OTP curriculum?
Topics: MAT, opioids, program development
In the News: Disasters and Opioid Treatment
That’s why I’d welcome more research into the tapering process, with an eye to improving success rates.
Topics: MAT, opioids, types of treatment
Is MAT Enough?
Of course with additional treatment responsibilities, a counselor couldn’t be expected to manage a caseload of up to 75.
Topics: MAT, opioids, program development, treatment models
The Cannabis Cure?
An answer such as vigorous exercise or meditation or going to a meeting will never be as universally attractive to someone a few weeks sober as “well, here, why don’t you toke this?”
Topics: cannabis, MAT, treatment models